You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Preliminary Results of a Population-Based Study of the Clinical Characteristics and Predictors of Major Gastrointestinal Bleeding among Oral Anticoagulant New Users with Atrial Fibrillation
- At: PSWC2020 (2020)
- Type: Poster
- By: QAZI, Jakub (University of Montreal, Faculty of Pharmacy, Pharmaceutical Sciences, Canada)
- Co-author(s): Jakub Qazi: Pharmaceutical Sciences, University of Montreal, Faculty of Pharmacy, Montreal, Canada
Mireille Schnitzer: Pharmaceutical Sciences, University of Montreal, Faculty of Pharmacy, Montreal, Canada
Marie-Josée Martel : Pharmaceutical Sciences, University of Montreal, Faculty of Pharmacy, Montreal, Canada
Marc Dorais: StatsSciences Inc., Notre-Dame-de-l'Île-Perrot, Canada
Sylvie Perreault: Pharmaceutical Sciences, University of Montreal, Faculty of Pharmacy, Montreal, Canada - Abstract:
Background
The real-world characteristics of patients with major gastrointestinal bleeding (GIB) have been well-studied among warfarin users, but less so among direct oral anticoagulants (DOAC) users with non-valvular atrial fibrillation (NVAF).Purpose
To assess the cumulative incidence of GIB for each DOAC (dabigatran, rivaroxaban and apixaban).. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026